Citations

Showing 10 of 108152 citations.

P‐tau/Aβ42 and Aβ42/40 ratios in CSF are equally predictive of amyloid PET status
Campbell, Michelle R. , Ashrafzadeh‐Kian, Susan , Petersen, Ronald C. , Syrjanen, Jeremy A. , Harten, Argonde C. van , Lowe, Val J. , Bornhorst, Joshua A. , van Harten, Argonde C, Algeciras-Schimnich, Alicia , Bornhorst, Joshua , Mielke, Michelle M. , Jack, Clifford R. , Algeciras‐Schimnich, Alicia

Mayo Clinic

Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring | May 18, 2021 | Volume: 13 | Issue: 1 | Pages: No page available

10.1002/dad2.12190 | PMID 34027020 Get It

Abstract Introduction Measurement of amyloid beta (Aβ40 and Aβ42) and tau (phosphorylated tau [p‐tau] and total tau [t‐tau]) in cerebrospinal fluid (CSF) can be utilized to differentiate clinical and preclinical Alzheimer's disease dementia (AD) from other neurodegenerative processes. Methods CSF biomarkers were measured in 150 participants from the Mayo Clinic Study of Aging and the Alzheimer's Disease Research Center. P‐tau/Aβ42 (Roche Elecsys, Fujirebio LUMIPULSE) and Aβ42/40 (Fujirebio LUMIPULSE) ratios were compared to one another and to amyloid positron emission tomography (PET) classification. Results Strong correlation was observed between LUMIPULSE p‐tau/Aβ42 and Aβ42/40, as well as Elecsys and LUMIPULSE p‐tau/Aβ42 and Aβ42/40 (Spearman's ρ = –0.827, –0.858, and 0.960, respectively). Concordance between LUMIPULSE p‐tau/Aβ42 and Aβ42/40 was 96% and between Elecsys p‐tau/Aβ42 and both LUMIPULSE ratios was 97%. All ratios had > 94% overall, positive, and negative percent agreement with amyloid PET classification. Discussion These data suggest that p‐tau/Aβ42 and Aβ42/40 ratios provide similar clinical information in the assessment of amyloid pathology.
Bilateral carotid webs
Essibayi, Muhammed Amir , Nasr, Deena M. , Nasr, Deena, Essibayi, Muhammed Amir , Lanzino, Giuseppe

Mayo Clinic

The Neuroradiology Journal | May 18, 2021 | Volume: 34 | Issue: 6 | Pages: 683-685

10.1177/19714009211017783 | PMID 34000900 Get It

Carotid web is thought to be a focal intimal variant of fibromuscular dysplasia, which comprises a high risk of stroke because of blood stasis and subsequent coagulative reactions that occur distal to the web. These lesions generally involve the posterolateral wall of the carotid and their developmental pathogenesis is controversial. This case report describes a 51-year-old woman who presented to the hospital with sudden onset aphasia, right hemi-sensory loss, and right visual field cut. Magnetic resonance imaging (MRI) of the brain demonstrated a left middle cerebral artery (MCA) distribution embolic ischemic infarct with shelf-like linear filling defects in the carotid bulb bilaterally on a computed tomography angiography (CTA) of the head and neck consistent with bilateral carotid webs that were confirmed by catheter angiography. The carotid webs were projecting on the left posteriorly and on the right anteriorly into the inferior aspects of the bilateral proximal internal carotid arteries. The patient was started on clopidogrel and a high-intensity statin and remained on Plavix monotherapy for a 10-month follow up without a recurrent ischemic event.
Integrating Health at Every Size principles into adolescent care
Raffoul, Amanda , Williams, Lesley

Mayo Clinic

Current Opinion in Pediatrics | May 18, 2021 | Volume: 33 | Issue: 4 | Pages: 361-367

10.1097/mop.0000000000001023 | PMID 34001715 Get It

Purpose of review Weight trends continue to increase in adolescents, but current weight-focused interventions have not demonstrated any lasting impact on overall health. Among adolescents, experiencing weight bias increases risks of harmful weight-related behaviors and decreases engagement in health-promoting behaviors, thus leading to worsened health outcomes. The Health at Every Size (HAES) approach may be an avenue to promote health holistically among adolescents without eliciting harmful weight-related behavior and improving provider-patient rapport. The purpose of this review is to summarize the literature on integrating HAES principles into healthcare and to generate recommendations for healthcare providers. Recent findings Research among adults shows that HAES-informed care can improve some physical health measures and generates improvements in behavioral and psychological outcomes, as well as promotion of social justice and equity. HAES-informed recommendations for adolescent care de-emphasize weight loss and focus on removing barriers to engaging in health-promoting behaviors at the point of assessment, in the diagnosis and management of medical complications, and in treatment. Summary HAES principles can be an invaluable tool for providers who aim to improve overall health whilst avoiding a focus on weight among their clients.
ZNF423 modulates the AMP-activated protein kinase pathway and metformin response in a single nucleotide polymorphisms, estrogen and selective estrogen receptor modulator dependent fashion
Kim, Wootae , Gao, Huanyao , Weinshilboum, Richard M. , Wang, Liewei , Ingle, James N. , Kim, Wootae , Qin, Sisi , Weinshilboum, Richard M.

Mayo Clinic

Pharmacogenetics and Genomics | May 18, 2021 | Volume: 31 | Issue: 7 | Pages: 155-164

10.1097/fpc.0000000000000435 | PMID 34001842 Get It

Objectives We previously discovered that the single nucleotide polymorphisms (SNP) rs9940645 in the ZNF423 gene regulate ZNF423 expression and serve as a potential biomarker for response to selective estrogen receptor modulators (SERMs). Here we explored pathways involved in ZNF423-mediated SERMs response and drugs that potentially sensitize SERMs. Methods RNA sequencing and label-free quantitative proteomics were performed to identify genes and pathways that are regulated by ZNF423 and the ZNF423 SNP. Both cultured cells and mouse xenograft models with different ZNF423 SNP genotypes were used to study the cellular responses to metformin. Results We identified ribosome and AMP-activated protein kinase (AMPK) signaling as potential pathways regulated by ZNF423 or ZNF423 rs9940645 SNP. Moreover, using clustered regularly interspaced short palindromic repeats/Cas9-engineered ZR75-1 breast cancer cells with different ZNF423 SNP genotypes, striking differences in cellular responses to metformin, either alone or in the combination of tamoxifen, were observed in both cell culture and the mouse xenograft model. Conclusions We found that AMPK signaling is modulated by the ZNF423 rs9940645 SNP in estrogen and SERM-dependent fashion. The ZNF423 rs9940645 SNP affects metformin response in breast cancer and could be a potential biomarker for tailoring the metformin treatment.
How should advance care planning be done when a surrogate is making decisions?
Cohen, Andrew , DeMartino, Erin S. , Cohen, Andrew B

Mayo Clinic

Journal of the American Geriatrics Society | May 18, 2021 | Volume: 69 | Issue: 8 | Pages: 2103-2105

10.1111/jgs.17222 | PMID 34002373 Get It

This editorial comments on the article by in der Schmitten et al . in this issue.
Different Prognostic Impact of the Morning Blood Pressure Surge in Heart Failure With Reduced vs. Preserved Ejection Fraction
Tada, Atsushi , Sorimachi, Hidemi, Omote, Kazunori

Mayo Clinic

Circulation Journal | May 17, 2021 | Volume: 85 | Issue: 9 | Pages: 1543-1544

10.1253/circj.cj-21-0311 | PMID 34011815 Get It

What Is the Role of the Cytosolic DNA Response in Neurodegeneration?
Benarroch, Eduardo E.

Mayo Clinic

Neurology | May 17, 2021 | Volume: 96 | Issue: 20 | Pages: 940-943

10.1212/wnl.0000000000011944 | PMID 34001541 Get It

Cefazolin and rifampin: A coagulopathy-inducing combination
Almeida, Natalia E. Castillo , Gurram, Pooja , Rivera, Christina G. , Castillo Almeida, Natalia E, Castillo, Natalia E , Rivera, Christina G , Stevens, Ryan W. , Suh, Gina A.

Mayo Clinic

American Journal of Health-System Pharmacy | May 17, 2021 | Volume: 78 | Issue: 24 | Pages: 2204-2208

10.1093/ajhp/zxab210 | PMID 34000006 Get It

Abstract Purpose To identify risk factors that may predispose patients to rifampin- and cefazolin-induced coagulopathy. Summary An 86-year-old man with a history of rheumatoid arthritis on chronic prednisone and stage 3 chronic kidney disease, notably not on warfarin, presented to the hospital with a 10-day history of right hip pain, swelling, and drainage after a recent right total-hip arthroplasty. The patient underwent a combination of surgical intervention and medication therapy with rifampin and ceftriaxone. After discharge and at postoperative day 9, ceftriaxone was changed to cefazolin due to increasing alkaline phosphatase levels. Four weeks after the initial debridement, antibiotics, and implant retention, the patient underwent a second irrigation and debridement due to persistent infection. Cefazolin and rifampin therapy was extended. Three days later, the patient presented to the emergency room with significant bleeding at the surgical site and a profoundly elevated prothrombin time and international normalized ratio (INR). No potential contributors were identified. The Naranjo adverse drug reaction probability scale identified cefazolin and rifampin as the probable cause of elevated INR. The Liverpool adverse drug reaction avoidability assessment tool classified this adverse event as “definitely avoidable.” Conclusion Rifampin-containing regimens are often recommended to treat staphylococcal prosthetic joint infections when the implant is retained. In methicillin-susceptible staphylococcal infections, cefazolin is routinely employed as the β-lactam backbone of definitive antimicrobial regimens. Although rifampin- and cefazolin-induced hypoprothrombinemia seems to be rare, adverse consequences of its occurrence may be prevented with appropriate monitoring.
Precision Medicine for Obesity
Cifuentes, Lizeth , Hurtado, Maria D. , Eckel‐Passow, Jeanette E. , Acosta, Andrés , Hurtado, Maria Daniela , Eckel-Passow, Jeanette, Acosta, Andres

Mayo Clinic

Digestive Disease Interventions | May 17, 2021 | Volume: 05 | Issue: 03 | Pages: 239-248

10.1055/s-0041-1729945 | PMID 36203650 Get It

Abstract Obesity is a multifactorial disease with a variable and underwhelming weight loss response to current treatment approaches. Precision medicine proposes a new paradigm to improve disease classification based on the premise of human heterogeneity, with the ultimate goal of maximizing treatment effectiveness, tolerability, and safety. Recent advances in high-throughput biochemical assays have contributed to the partial characterization of obesity's pathophysiology, as well as to the understanding of the role that intrinsic and environmental factors, and their interaction, play in its development and progression. These data have led to the development of biological markers that either are being or will be incorporated into strategies to develop personalized lines of treatment for obesity. There are currently many ongoing initiatives aimed at this; however, much needs to be resolved before precision obesity medicine becomes common practice. This review aims to provide a perspective on the currently available data of high-throughput technologies to treat obesity.
Second-Generation Highly Cross-Linked Polyethylene in Total Hip Arthroplasty
Parekh, Amit , Sood, Anshum , Monsef, Jad Bou , Hamouda, Mohammed , Hussain, Awais K. , Gonzalez, Mark H. , Parekh, Amit , Hussain, Awais , Gonzalez, Mark , Parekh, Amit , Hamouda, Mohammed

Mayo Clinic

JBJS Reviews | May 17, 2021 | Volume: 9 | Issue: 4 | Pages: No page available

10.2106/jbjs.rvw.20.00065 | PMID 33982980 Get It

» Bearing materials that are used in total hip arthroplasty have undergone major developments in structure and durability since the 1960s. » Osteolysis and aseptic loosening associated with ultra-high molecular weight polyethylene had been a major concern; this led to the development of the first generation of highly cross-linked polyethylene (HXLPE), which was followed by a second generation of HXLPE. » The second generation of HXLPE was introduced with the aim of providing oxidative stability while maintaining high wear resistance. » Oxidative stabilization methods include mechanical deformation and annealing, incorporation of antioxidant-containing materials, high-pressure crystallization after melting, and polyethylene surface-grafting with a biocompatible polymer. » Results of clinical studies with ≤5 years of follow-up have shown that second-generation HXLPE acetabular liners are superior to any of the previous generation with regard to wear rates; however, additional studies are needed to compare second-generation materials among each other.